A true pioneer in hearing restoration, Dr. Staeker stands among the few scientists who have truly made history in this field. As a medical leader and visionary at the University of Kansas, he achieved what many thought impossible—creating the first-ever gene therapy for hearing loss approved for human clinical trials (Novartis CGF166). This breakthrough didn't just advance science; it opened an entirely new frontier of possibility for millions affected by hearing loss worldwide. At RHI, Dr. Staeker brings this same boundary-breaking innovation to our mission, guiding our scientific strategy with unparalleled expertise and a proven track record of turning revolutionary ideas into clinical realities.